GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of small win: Canada stopped being a problem at week 80 — 24 comments in the full submission. View in context.
486
c/glp1canada·submitted 2 months ago by u/aleksi_grimaldi

small win: Canada stopped being a problem at week 80

Formularybranch of 8 comments

Right, the private plan question again, but with numbers this time. I have 7 data points over 8 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…

Read the full submission and all 24 comments →

This branch

8 comments, started 1 months ago
u/laila_wojcik13 points·1 months ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/greta_perrin9 points·1 months ago

private plans vary by employer

replysharereportpermalink
u/zeynep_ndiaye4 points·1 months ago

the 19 province variation is real

replysharereportpermalink
u/dario_vermeulen6 points·1 months ago

the 19 province variation is real

Adding to this: special authorization is doing more work than the comment implies.

replysharereportpermalink
u/aleksi_grimaldiOP2 points·1 months ago

the 19 province variation is real

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/kavya_kravchenko7 points·1 months ago·edited

private plan details: redact your group number

replysharereportpermalink
u/isabela_guerrero4 points·1 months ago

Small correction: the trial was 11 weeks, not 16. Does not change your point but people will quote it.

replysharereportpermalink
u/ffmi_watcher13 points·1 months ago

private plans vary by employer

Yes, exactly this, and it is the bit that took me 51 weeks to accept.

replysharereportpermalink

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.